Genetic risk of type 2 diabetes in populations of the African continent: A systematic review and meta-analyses

Diabetes Research and Clinical Practice

Volumn 114, Issue , 2016, Pages 136-150

  Yako, Yandiswa Y ^a,b   Guewo Fokeng, Magellan ^c   Balti, Eric V ^d   Bouatia Naji, Nabila ^e,f   Matsha, Tandi E ^b   Sobngwi, Eugene ^c   Erasmus, Rajiv T ^g   Echouffo Tcheugui, Justin B ^h,i   Kengne, Andre P ^a,j,k  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^e PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITY OF STELLENBOSCH   (South Africa)

^h EMORY UNIVERSITY   (United States)

ⁱ MEDSTAR HEALTH RESEARCH INSTITUTE   (United States)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

^k UNIVERSITY OF SYDNEY   (Australia)

more..

Author keywords

Africa; Genetics; Type 2 diabetes

Indexed keywords

ACE GENE; AFRICA; AGRP GENE; ARTICLE; CLINICAL EXAMINATION; DATA BASE; ENOS GENE; ENVIRONMENTAL FACTOR; ETHNICITY; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GSTP1 GENE; HSP70 2 GENE; HUMAN; MC4R GENE; META ANALYSIS; MTHFR GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHLPP GENE; POL1 GENE; POPULATION GENETICS; POPULATION RESEARCH; SYSTEMATIC REVIEW; TCF7L2 GENE; TNF ALPHA GENE; BLACK PERSON; DIABETES MELLITUS, TYPE 2; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC MARKER;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84955599389     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.01.003     Document Type: Article

References (92)

1. Kengne A.P., Echouffo-Tcheugui J., Sobgnwi E., Mbanya J.C. New insights on diabetes mellitus and obesity in Africa. Part 1: prevalence, pathogenesis and comorbidities. Heart 2013, 99:979-983.
2. Peer N., Kengne A.P., Motala A.A., Mbanya J.C. Diabetes in the Africa region: 2013 update for the IDF diabetes Atlas. Diabetes Res Clin Pract 2014, 103(2):197-205.
3. Kaprio J., Tuomilehto J., Koskenvuo M., Romanov K., Reunanen A., Eriksson J., et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992, 35:1060-1067.
4. Groop L., Forsblom C., Lehtovirta M., Tuomi T., Karanko S., Nissen M., et al. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes. 1996, 45:1585-1593.
5. Morris A.P., Voight B.F., Teslovich T.M., Ferreira T., Segre A.V., Steinthorsdottir V., et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012, 44:981-990.
6. Sohani Z.N., Deng W.Q., Pare G., Meyre D., Gerstein H.C., Anand S.S. Does genetic heterogeneity account for the divergent risk of type 2 diabetes in South Asian and white European populations?. Diabetologia 2014, 57:2270-2281.
7. Petersen D.C., Libiger O., Tindall E.A., Hardie R.A., Hannick L.I., Glashoff R.H., et al. Complex patterns of genomic admixture within southern Africa. PLoS Genet 2013, 9:e1003309.
8. Genomes Project C., Abecasis G.R., Auton A., Brooks L.D., DePristo M.A., Durbin R.M., et al. An integrated map of genetic variation from 1092 human genomes. Nature 2012, 491:56-65.
9. Sagoo G.S., Little J., Higgins J.P. Systematic reviews of genetic association studies. PLoS Med 2009, 6:e28. [Human Genome Epidemiology Network].
10. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br Med J 2003, 327:557-560.
11. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002, 21:1539-1558.
12. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997, 315:629-634.
13. Sterne J.A., Sutton A.J., Ioannidis J.P., Terrin N., Jones D.R., Lau J., et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. Br Med J 2011, 343:d4002.
14. Anzures-Cabrera J., Higgins J.P. Graphical displays for meta-analysis: an overview with suggestions for practice. Res Synth Methods 2010, 1:66-80.
15. Rotimi C.N., Chen G., Adeyemo A.A., Furbert-Harris P., Parish-Gause D., Zhou J., et al. A genome-wide search for type 2 diabetes susceptibility genes in West Africans: the Africa America Diabetes Mellitus (AADM) study. Diabetes 2004, 53:838-841.
16. Chen G., Adeyemo A., Zhou J., Chen Y., Huang H., Doumatey A., et al. Genome-wide search for susceptibility genes to type 2 diabetes in West Africans: potential role of C-peptide. Diabetes Res Clin Pract 2007, 78:e1-e6.
17. Mtiraoui N., Ezzidi I., Turki A., Chaieb A., Mahjoub T., Almawi W.Y. Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs. Diabetes Res Clin Pract 2012, 97:290-297.
18. Schwarz P.E., Towers G.W., van der Merwe A., Perez-Perez L., Rheeder P., Schulze J., et al. Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives. Pharmacogenomics J 2009, 9:42-48.
19. Danquah I., Othmer T., Frank L.K., Bedu-Addo G., Schulze M.B., Mockenhaupt F.P. The TCF7L2 rs7903146 (T) allele is associated with type 2 diabetes in urban Ghana: a hospital-based case-control study. BMC Med Genet 2013, 14:96.
20. Ouederni T.B., Sanchez-Corona J., Skhiri H.A., Maiz H.B., Abid H.K., Benammar-Elgaaied A. [Study of association of the SNP19 polymorphism of calpain 10 gene with type 2 diabetes in ethnic sub-groups of the Tunisian population: gene-environment interaction]. Ann Biol Clin (Paris) 2009, 67:171-176.
21. Ezzidi I., Mtiraoui N., Nemr R., Kacem M., Al-Khateeb G.M., Mahjoub T., et al. Variants within the calpain-10 gene and relationships with type 2 diabetes (T2DM) and T2DM-related traits among Tunisian Arabs. Diabetes Metab 2010, 36:357-362.
22. Kifagi C., Makni K., Mnif F., Boudawara M., Hamza N., Rekik N., et al. Association of calpain-10 polymorphisms with type 2 diabetes in the Tunisian population. Diabetes Metab 2008, 34:273-278.
23. Chen Y., Kittles R., Zhou J., Chen G., Adeyemo A., Panguluri R.K., et al. Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: the Africa America Diabetes Mellitus (AADM) study. Ann Epidemiol 2005, 15:153-159.
24. Mtiraoui N., Turki A., Nemr R., Echtay A., Izzidi I., Al-Zaben G.S., et al. Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARgamma, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs. Diabetes Metab. 2012, 38:444-449.
25. Cauchi S., El Achhab Y., Choquet H., Dina C., Krempler F., Weitgasser R., et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med (Berl) 2007, 85:777-782.
26. Bouhaha R., Choquet H., Meyre D., Abid Kamoun H., Ennafaa H., Baroudi T., et al. TCF7L2 is associated with type 2 diabetes in nonobese individuals from Tunisia. Pathol Biol (Paris) 2010, 58:426-429.
27. Ezzidi I., Mtiraoui N., Cauchi S., Vaillant E., Dechaume A., Chaieb M., et al. Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study. BMC Med Genet 2009, 10:33.
28. Kifagi C., Makni K., Boudawara M., Mnif F., Hamza N., Abid M., et al. Association of genetic variations in TCF7L2, SLC30A8, HHEX, LOC387761, and EXT2 with Type 2 diabetes mellitus in Tunisia. Genet Test Mol Biomark 2011, 15:399-405.
29. Turki A., Al-Zaben G.S., Mtiraoui N., Marmmuoch H., Mahjoub T., Almawi W.Y. Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Tunisian Arab subjects. Gene 2013, 513:244-248.
30. Helgason A., Palsson S., Thorleifsson G., Grant S.F., Emilsson V., Gunnarsdottir S., et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007, 39:218-225.
31. Bouhaha R., Baroudi T., Ennafaa H., Vaillant E., Abid H., Sassi R., et al. Study of TNFalpha -308G/A and IL6-174G/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population. Clin Biochem 2010, 43:549-552.
32. Kallel A., Ftouhi B., Jemaa Z., Mahjoubi I., Feki M., Slimane H., et al. Tumor necrosis factor-α (TNF-α) -863C/A promoter polymorphism is associated with type 2 diabetes in Tunisian population. Diabetes Res Clin Pract 2013, 102:e24-e28.
33. Zouari Bouassida K., Chouchane L., Jellouli K., Cherif S., Haddad S., Gabbouj S., et al. Polymorphism of stress protein HSP70-2 gene in Tunisians: susceptibility implications in type 2 diabetes and obesity. Diabetes Metab 2004, 30:175-180.
34. McCarthy M.I. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010, 363:2339-2350.
35. Ng M.C., Shriner D., Chen B.H., Li J., Chen W.M., Guo X., et al. Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes. PLoS Genet 2014, 10:e1004517.
36. Travers M.E., McCarthy M.I. Type 2 diabetes and obesity: genomics and the clinic. Hum Genet 2011, 130:41-58.
37. Morris A.P. Fine mapping of type 2 diabetes susceptibility loci. Curr Diab Rep 2014, 14:549.
38. Chowdhury R., Narayan K.M., Zabetian A., Raj S., Tabassum R. Genetic studies of type 2 diabetes in South Asians: a systematic overview. Curr Diabetes Rev 2014, 10:258-274.
39. DIAbetes Genetics Replication Meta-analysis (DIAGRAM) Consortium, Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 2014, 46:234-244.
40. O'Rahilly S. Human genetics illuminates the paths to metabolic disease. Nature 2009, 462:307-314.
41. Attfield K.E., Dendrou C.A., Fugger L. Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis. Immunol Rev 2012, 248:10-22.
42. Echouffo-Tcheugui J.B., Dieffenbach S.D., Kengne A.P. Added value of novel circulating and genetic biomarkers in type 2 diabetes prediction: a systematic review. Diabetes Res Clin Pract 2013, 101(3):255-269.
43. Langenberg C., Sharp S.J., Franks P.W., Scott R.A., Deloukas P., Forouhi N.G., et al. Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study. PLoS Med 2014, 11:e1001647.
44. Mbanya J.C., Motala A.A., Sobngwi E., Assah F.K., Enoru S.T. Diabetes in sub-Saharan Africa. Lancet 2010, 375:2254-2266.
45. Kato N. Insights into the genetic basis of type 2 diabetes. J Diabetes Investig 2013, 4:233-244.
46. Gupta V., Vinay D.G., Sovio U., Rafiq S., Kranthi Kumar M.V., Janipalli C.S., et al. Association study of 25 type 2 diabetes related Loci with measures of obesity in Indian sib pairs. PLoS One 2013, 8:e53944.
47. Hasstedt S.J., Hanis C.L., Das S.K., Elbein S.C. Pleiotropy of type 2 diabetes with obesity. J Hum Genet 2011, 56:491-495.
48. Kraja A.T., Chasman D.I., North K.E., Reiner A.P., Yanek L.R., Kilpelainen T.O., et al. Pleiotropic genes for metabolic syndrome and inflammation. Mol Genet Metab 2014, 112:317-338.
49. de Vries J., Tindana P., Littler K., Ramsay M., Rotimi C., Abayomi A., et al. The H3Africa policy framework: negotiating fairness in genomics. Trends in genetics: TIG 2015, 31:117-119.
50. Consortium H.A., Rotimi C., Abayomi A., Abimiku A., Adabayeri V.M., Adebamowo C., et al. Research capacity. Enabling the genomic revolution in Africa. Science 2014, 344:1346-1348.
51. Katchunga P.B., Baguma M., M'Buyamba-Kabangu J.R., Philippe J., Hermans M.P., Delanghe J. Ferroportin Q248H mutation, hyperferritinemia and atypical type 2 diabetes mellitus in South Kivu. Diabetes Metab Syndr 2013, 7:112-115.
52. Helaly M., Hatata E., Abu-Elmagd M., Ibrahem E., Alsaid A., AbdEl-Aal I., et al. Association of IL-10 and IL-6 gene polymorphisms with type 2 diabetes mellitus among Egyptian patients. Eur J General Med 2013, 10:158-162.
53. AbdRaboh N.R., Badr S., Ali S. Prevalence of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Egyptian patients with type 2 diabetes mellitus. Egypt J Med Hum Genet 2013, 14:87-93.
54. Alsaid A., El-Missiry M., Hatata el S., Tarabay M., Settin A. Association of IL-4-590 C > T and IL-13-1112 C > T gene polymorphisms with the susceptibility to type 2 diabetes mellitus. Disease Markers 2013, 35:243-247.
55. Amer M.A., Ghattas M.H., Abo-Elmatty D.M., Abou-El-Ela S.H. Influence of glutathione S-transferase polymorphisms on type-2 diabetes mellitus risk. Genet Mol Res: GMR 2011, 10:3722-3730.
56. Amer M.A., Ghattas M.H., Abo-Elmatty D.M., Abou-El-Ela S.H. Evaluation of glutathione S-transferase P1 genetic variants affecting type-2 diabetes susceptibility and glycemic control. Arch Med Sci: AMS 2012, 8:631-636.
57. Elsaid A., Helaly M., Hatata E., Fouda O., Settin A. TNF-(alpha)-308 and INF-(gamma) +874 gene polymorphisms in relation to susceptibility and severity of type 2 diabetes mellitus among egyptian cases. Eur J General Med 2012, 9:173-177.
58. El-Shal A.S., Pasha H.F., Rashad N.M. Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients. Gene 2013, 515:233-238.
59. El-Sherbini S.M., Shahen S.M., Mosaad Y.M., Abdelgawad M.S., Talaat R.M. Gene polymorphism of transforming growth factor-beta1 in Egyptian patients with type 2 diabetes and diabetic nephropathy. Acta Biochim Biophys Sin 2013, 45:330-338.
60. Ghattas M.H., Amer M.A. Possible role of microsomal epoxide hydrolase gene polymorphism as a risk factor for developing insulin resistance and type 2 diabetes mellitus. Endocrine 2012, 42:577-583.
61. Settin A., El-Baz R., Ismaeel A., Tolba W., Allah W.A. Association of ACE and MTHFR genetic polymorphisms with type 2 diabetes mellitus: susceptibility and complications. J Renin-Angiotensin-Aldosterone Syst: JRAAS 2014, 16(4):838-843.
62. Zarouk W.A., Hussein I.R., Esmaeil N.N., Raslan H.M., Reheim H.A., Moguib O., et al. Association of angiotensin converting enzyme gene (I/D) polymorphism with hypertension and type 2 diabetes. Bratisl Lek Listy 2012, 113:14-18.
63. Abdelhamid I., Lasram K., Meiloud G., Ben Halim N., Kefi R., Samb A., et al. E23K variant in KCNJ11 gene is associated with susceptibility to type 2 diabetes in the Mauritanian population. Prim Care Diabetes 2014, 8:171-175.
64. Chiu K.C., Province M.A., Dowse G.K., Zimmet P.Z., Wagner G., Serjeantson S., et al. A genetic marker at the glucokinase gene locus for type 2 (non-insulin-dependent) diabetes mellitus in Mauritian Creoles. Diabetologia 1992, 35:632-638.
65. Benrahma H., Abidi O., Melouk L., Ajjemami M., Rouba H., Chadli A., et al. Association of the C677T polymorphism in the human methylenetetrahydrofolate reductase (MTHFR) gene with the genetic predisposition for type 2 diabetes mellitus in a Moroccan population. Genet Test Mol Biomark 2012, 16:383-387.
66. Benrahma H., Charoute H., Lasram K., Boulouiz R., Atig R.K., Fakiri M., et al. Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis. Biochem Genet 2014, 52:430-442.
67. Cauchi S., Meyre D., Durand E., Proenca C., Marre M., Hadjadj S., et al. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One 2008, 3:e2031.
68. El Achhab Y., Meyre D., Bouatia-Naji N., Berraho M., Deweirder M., Vatin V., et al. Association of the ENPP1 K121Q polymorphism with type 2 diabetes and obesity in the Moroccan population. Diabetes Metab 2009, 35:37-42.
69. Lopez-Sall P., Bard J.M., Nazih H., Cisse A., Bobin-Dubigeon C., Sall N.D. [PPAR alpha-L162V, frequency and relationship with type 2 diabetes among black Senegalese people]. Ann Biol Clin (Paris) 2008, 66:475-477.
70. Olckers A., Towers G.W., van der Merwe A., Schwarz P.E., Rheeder P., Schutte A.E. Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 2007, 56:587-592.
71. Panz V.R., Raal F.J., O'Rahilly S., Kedda M.A., Joffe B.I. Insulin receptor substrate-1 gene variants in lipoatrophic diabetes mellitus and non-insulin-dependent diabetes mellitus: a study of South African black and white subjects. Hum Genet 1997, 101:118-119.
72. Vergotine Z., Yako Y.Y., Kengne A.P., Erasmus R.T., Matsha T.E. Proliferator-activated receptor gamma Pro12Ala interacts with the insulin receptor substrate 1 Gly972Arg and increase the risk of insulin resistance and diabetes in the mixed ancestry population from South Africa. BMC Genet 2014, 15:10.
73. Arfa I., Abid A., Nouira S., Elloumi-Zghal H., Malouche D., Mannai I., et al. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. J Renin-Angiotensin-Aldosterone Syst: JRAAS 2008, 9:32-36.
74. Baroudi T., Bouhaha R., Moran-Moguel C., Sanchez-Corona J., Ben Maiz H., Kammoun Abid H., et al. Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia. J Renin-Angiotensin-Aldosterone Syst: JRAAS 2009, 10:35-40.
75. Ouederni T.B., Sanchez-Corona J., Flores Martinez S.E., Ben Maiz H., Skhiri H.A., Abid H.K., et al. The G1057D polymorphism of IRS-2 gene is not associated with type 2 diabetes and obese patients among ethnic groups in Tunisian population. Clin Biochem 2009, 42:1169-1173.
76. Ouederni T.B., Fadiel A., Stambouli N., Scalize T.J., Ben Maiz H., Abid H.K., et al. Influence of socioeconomic lifestyle factors and genetic polymorphism on type 2 diabetes occurrences among Tunisian Arab and Berber groups of Djerba Island. Pharmacogenomics Pers Med 2009, 2:49-57.
77. Bouhaha R., Meyre D., Kamoun H.A., Ennafaa H., Vaillant E., Sassi R., et al. Effect of ENPP1/PC-1-K121Q and PPARgamma-Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population. Diabetes Res Clin Pract 2008, 81:278-283.
78. Chaaba R., Attia N., Hammami S., Smaoui M., Mahjoub S., Hammami M., et al. Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes. Lipids Health Disease 2005, 4:1.
79. Ezzidi I., Mtiraoui N., Mohamed M.B., Mahjoub T., Kacem M., Almawi W.Y. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. J Diabetes Complicat 2008, 22:331-338.
80. Ezzidi I., Turki A., Messaoudi S., Chaieb M., Kacem M., Al-Khateeb G.M., et al. Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study. BMC Med Genet 2010, 11:75.
81. Jemaa Z., Kallel A., Sleimi C., Mahjoubi I., Feki M., Ftouhi B., et al. The Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is associated with type 2 diabetes in Tunisian population. Diabetes Metab Syndr 2015, 9(4):316-319.
82. Koubaa N., Nakbi A., Smaoui M., Abid N., Chaaba R., Abid M., et al. Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: role of genetic and dietary factors. Clin Biochem 2007, 40:1007-1014.
83. Makni K., Mnif F., Boudawara M., Hamza N., Rekik N., Abid M., et al. Association of glucose transporter 1 polymorphisms with type 2 diabetes in the Tunisian population. Diabetes Metab Res Rev 2008, 24:544-548.
84. Mehri S., Koubaa N., Nakbi A., Hammami S., Chaaba R., Mahjoub S., et al. Relationship between genetic polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase as risk factors for type 2 diabetes in Tunisian patients. Clin Biochem 2010, 43:259-266.
85. Mehri S., Koubaa N., Hammami S., Mahjoub S., Chaaba R., Nakbi A., et al. Genotypic interactions of renin-angiotensin system genes with diabetes type 2 in a Tunisian population. Life Sci 2010, 87:49-54.
86. Mtiraoui N., Ezzidi I., Kacem M., Ben Hadj Mohamed M., Chaieb M., Haj Jilani A.B., et al. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients. Diabetes Metab Res Rev 2009, 25:57-63.
87. Nouira S., Arfa I., Kammoun I., Abid A., Ouragini H., Dorboz I., et al. Identification of two novel variants in PRKAG2 gene in Tunisian type 2 diabetic patients with family history of cardiovascular disease. Diabetes Res Clin Pract 2010, 87:e7-e10.
88. Oudi M.E., Aouni Z., Mazigh C., Essaies O., Zidi B., Machghoul S. C677T Polymorphism of MTHFR gene in a Tunisian type 2 diabetic population. Immuno-Anal Biol Spéc 2008, 23:220-223.
89. Turki A., Mtiraoui N., Al-Busaidi A.S., Khirallah M., Mahjoub T., Almawi W.Y. Lack of association between genetic polymorphisms within KCNQ1 locus and type 2 diabetes in Tunisian Arabs. Diabetes Res Clin Pract 2012, 98:452-458.
90. Turki A., Mahjoub T., Mtiraoui N., Abdelhedi M., Frih A., Almawi W.Y. Association of POL1, MALT1, MC4R, PHLPP and DSEL single nucleotide polymorphisms in chromosome 18q region with type 2 diabetes in Tunisians. Gene 2013, 527:243-247.
91. Zouari Bouassida K., Chouchane L., Jellouli K., Cherif S., Haddad S., Gabbouj S., et al. The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients. Diabetes Metab 2005, 31:119-123.
92. Bonilla C., Panguluri R.K., Taliaferro-Smith L., Argyropoulos G., Chen G., Adeyemo A.A., et al. Agouti-related protein promoter variant associated with leanness and decreased risk for diabetes in West Africans. Int J Obes (Lond) 2006, 30:715-721.